Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

AI Briefing

• – Nxera Pharma receives $10 million payment from AbbVie for R&D milestone.
• – Collaboration targets neurological diseases.
• – Nxera Pharma Co. Ltd. receives payment under multi-target discovery collaboration with AbbVie.